IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors

Chimeric antigen receptor (CAR) T cell therapy has been highly successful in hematological malignancies leading to their US Food and Drug Administration (FDA) approval. However, the efficacy of CAR T cells in solid tumors is limited by tumor-induced immunosuppression, leading to the development of c...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Ther
Main Authors: Giuffrida, Lauren, Sek, Kevin, Henderson, Melissa A., House, Imran G., Lai, Junyun, Chen, Amanda X.Y., Todd, Kirsten L., Petley, Emma V., Mardiana, Sherly, Todorovski, Izabela, Gruber, Emily, Kelly, Madison J., Solomon, Benjamin J., Vervoort, Stephin J., Johnstone, Ricky W., Parish, Ian A., Neeson, Paul J., Kats, Lev M., Darcy, Phillip K., Beavis, Paul A.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Gene & Cell Therapy 2020
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7647667/
https://ncbi.nlm.nih.gov/pubmed/32735774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2020.07.018
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker